Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 10
Investors Cheer, Analysts Caution In Wake of FDA Advisory Panel News
Panel Recommends Keeping Celebrex, Bextra on the Market;
Says Vioxx May Return
Researchers Publish Cardiovascular Risk Analysis Of APPROVe Study
Judge Dismisses Enbrel Negligence Claims, Allows Defect Claims
Order Dismisses Negligence, Products Claims in Celebrex Suit
Judge Says Plaintiff Never Intended to Pursue Claims Against Physician, Denies Remand
Plaintiff Seeks May 31 Trial Setting, as Parties Dispute Discovery in Vioxx Case
Complaint Says Plaintiffs' Injuries Were Caused by Celebrex, Bextra & Vioxx
